CN112535690A - Oxygen supply and sterilization integrated ozone eye cleaning and nursing lotion - Google Patents
Oxygen supply and sterilization integrated ozone eye cleaning and nursing lotion Download PDFInfo
- Publication number
- CN112535690A CN112535690A CN201910930747.XA CN201910930747A CN112535690A CN 112535690 A CN112535690 A CN 112535690A CN 201910930747 A CN201910930747 A CN 201910930747A CN 112535690 A CN112535690 A CN 112535690A
- Authority
- CN
- China
- Prior art keywords
- lotion
- eye
- eye cleaning
- nursing
- cleaning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 59
- 238000004140 cleaning Methods 0.000 title claims abstract description 55
- 230000000474 nursing effect Effects 0.000 title claims abstract description 48
- 239000001301 oxygen Substances 0.000 title claims abstract description 17
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 title claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title abstract description 13
- 238000004659 sterilization and disinfection Methods 0.000 title description 9
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 title description 4
- 210000001508 eye Anatomy 0.000 claims abstract description 79
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 40
- 238000002156 mixing Methods 0.000 claims abstract description 24
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 15
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000012153 distilled water Substances 0.000 claims abstract description 15
- 235000011187 glycerol Nutrition 0.000 claims abstract description 15
- 229940041616 menthol Drugs 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 230000000694 effects Effects 0.000 claims abstract description 8
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims abstract 7
- 239000000203 mixture Substances 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 230000003204 osmotic effect Effects 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 230000003020 moisturizing effect Effects 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 210000005252 bulbus oculi Anatomy 0.000 claims 1
- 210000000744 eyelid Anatomy 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 13
- 210000004087 cornea Anatomy 0.000 abstract description 6
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract description 5
- 206010013774 Dry eye Diseases 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 208000003464 asthenopia Diseases 0.000 abstract description 3
- 206010015943 Eye inflammation Diseases 0.000 abstract 1
- 239000007789 gas Substances 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 238000012827 research and development Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 18
- KQBSGRWMSNFIPG-UHFFFAOYSA-N trioxane Chemical compound C1COOOC1 KQBSGRWMSNFIPG-UHFFFAOYSA-N 0.000 description 15
- 210000004379 membrane Anatomy 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 4
- 239000003637 basic solution Substances 0.000 description 4
- 239000003889 eye drop Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 210000003560 epithelium corneal Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000028006 Corneal injury Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 208000020564 Eye injury Diseases 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008378 epithelial damage Effects 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 206010023365 keratopathy Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- -1 lipid peroxides Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses an eye cleaning and nursing lotion for dry eye and eye fatigue, which comprises an eye lotion composition and tri-distilled water, wherein a novel gas-liquid mixing device is utilized, the operation is simple, convenient and rapid, and the lotion preparation can be completed anytime and anywhere, and the eye lotion composition comprises a trioxane solution, menthol and glycerin. The raw materials are easy to obtain, the cost is low, the operation is simple, the existing preparation can be realized, and the purity and the titer are ensured; meanwhile, the eye lotion can be industrially produced in large scale, and the eye lotion can be packaged in small packages and separated from gas and liquid. The invention applies the trioxane to the eye cleaning and nursing lotion, and the trioxane solution can obviously increase the oxygen supply to the cornea, reduce the eye inflammation reaction and inhibit the activity of pathogenic microorganisms of the eyes, thereby providing a new idea for the research and development of a new generation of eye protection solution.
Description
Technical Field
The invention particularly relates to an eye cleaning and nursing lotion and a preparation method thereof, and particularly relates to application of trioxane in the eye cleaning and nursing lotion.
Technical Field
1. The oxygen supply to the cornea of the eye is only 15% from the respiratory system, the other 85% being obtained by contact with the outside air;
2. the modern people are easy to cause dry eyes and unsmooth eyes when staring at electronic products for a long time, and if the modern people stare at the electronic products for a long time, the eyesight is easy to decline;
3. in order to seek beauty, people wear the beauty pupil, so that the effective oxygen acquisition time in contact with air is shortened, the eye is anoxic, the corneal epithelium is pathologically changed in the anoxic state, the mitosis process of cells is delayed, the cell number is reduced, the epithelial layer is thinned, the epithelial cells are easy to peel off due to enzyme dysfunction, and symptoms such as dry eyes, acid swelling of eyes, blurred vision and the like are easily caused, and even the vision is reduced.
Corneal epithelial damage refers to the partial or complete loss of epithelial cells resulting from the disruption of the barrier function of corneal epithelial cells or the invasion of the integrity of corneal epithelium for various reasons. At the same time, inflammatory reactions may occur simultaneously, and may even lead to corneal stromal lesions, affecting vision. Cell damage by oxygen radicals can be caused not only by peroxidation of polyunsaturated fatty acids in biological membranes but also by breakdown products of lipid peroxides. Therefore, the data detected by MDA represents the lipid peroxidation degree in the organism and indirectly represents the cell damage degree; the detection of SOD activity indirectly reflects the size of the clearance capability of the substrate for oxygen free radicals. In addition, clinically, patients who are unconscious or sedated in intensive care units lose moisture and corneal injury due to long-term corneal exposure, and patients who are bedridden and have systemic infection are combined, so that the probability of secondary infection of eyes is increased, and the secondary eye injury is caused.
The current way to relieve eye fatigue is to let the eyes rest; or hot compress and cold compress are alternated and repeated for several times; or the eye cleaning and nursing lotion for moistening and cleaning eyes is used, but the existing eye cleaning and nursing lotion in the market only has the function of temporarily moistening the cornea, has short action time, and can possibly cause inflammatory reaction after being used for multiple times in short time, thereby aggravating the uncomfortable feeling of the eyes. Therefore, how to find new drugs for treating the common symptoms of ophthalmology has become a hotspot and difficulty in the current research of ophthalmology. According to clinical requirements, the ozone eye cleaning and nursing lotion with the two-in-one effects of oxygen supply and sterilization is further developed.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, improve the oxygen supply of eyes to relieve the symptoms of dry eyes, eye infection and the like caused by electronic products and contact lenses, and the condition of the keratopathy in the blind eye diseases is very severe at present. The ozone has strong dissolving capacity, high oxidizing capacity, strong oxidizer property and strong sterilization and antibacterial effects. After 4 years of experimental development, the eye and eye cleaning and nursing lotion using the trioxane as the raw material is developed. The eye cleaning and nursing lotion can obviously improve the oxygen supply of the cornea and inhibit the eye inflammatory reaction.
Technical scheme of the invention
Material preparation process
(1) Preparation of trioxane
High-voltage static electricity generated by surface discharge of high-frequency ceramic is utilized to ionize oxygen molecules in the air near the electrode, and the oxygen is generated in a short time.
(2) Screening of menthol raw material
Selecting medical special menthol
(3) Glycerol raw material screening
Selecting medical special glycerin
Preparation of mixed aqueous solution
Adding glycerol and menthol into a high-efficiency gas-water turbine mixer according to the mass ratio of 28: 1 for mixing, adding the prepared mixed solution into 10ml of triple distilled water, adding into the high-efficiency gas-water turbine mixer, and fully mixing to prepare a mixed aqueous solution.
Preparation of Sanxiong original liquid
Adding trioxyme and mixed water solution into a novel gas-liquid mixing device according to the volume ratio of 126: 25, fully mixing, adjusting the pH value of the prepared trioxyme raw solution to 7.2-7.4, adjusting the osmotic pressure to 240-290mOsm/L, filtering and sterilizing through a 0.2 mu m membrane, and finally preparing the trioxyme eye cleaning care solution by using a sterile medical device.
Four-oxygen and three-oxygen care solution
Subpackaging 15ml of trioxane nursing liquid
Compared with the prior art, the invention has the following beneficial effects:
the invention discloses an application of a trioxane solution in an eye cleaning and nursing lotion, which has the following advantages:
1. can obviously reduce the inflammatory reaction of the eyes,
2. the oxygen supply of the cornea is increased,
3. no secondary infection caused by using eye antibiotics.
The invention has the beneficial effects that:
1. the preparation method of the eye cleaning and nursing lotion is simple, reliable and easy to implement;
2. the eye cleaning and nursing lotion is prepared at present and has high purity;
3. the eye cleaning and nursing lotion has simple components, relatively low cost and convenient preparation;
4. the menthol with a certain dosage is added into the eye cleaning and nursing lotion, so that the transdermal degree of the medicine can be obviously improved, and the effect is obvious;
5. the glycerin with a certain dosage is added into the eye cleaning and nursing lotion, so that the comfort of eyes can be obviously improved, and the eye cleaning and nursing lotion has a moisturizing effect;
6. the eye cleaning and nursing lotion of the invention does not add hormone components, can be used for a long time, and greatly reduces complications and sequelae during the application;
7. the eye cleaning and nursing lotion disclosed by the invention is not added with antibiotics, is purely natural and pollution-free, and can be used for treating corneal inflammation and playing a certain role in repairing corneal epithelium after being applied to a rat corneal alkali burn model;
8. the eye cleaning and nursing lotion provided by the invention can be used for beautifying pupils, bringing great convenience to contact lens users, keeping eye health and keeping away from eye diseases.
9. The eye cleaning and nursing lotion provided by the invention is effectively convenient for staff to use computer eyes for a long time, dry eyes, eye fatigue and other symptoms.
10. The eye cleaning and nursing lotion can facilitate the work of a clinician, and provides more reasonable operation time for preoperative control and stabilization of the cornea inflammatory disease and the condition of the patient with corneal epithelial defect;
11. the eye cleaning and nursing lotion can be used for resisting corneal inflammatory diseases and corneal epithelial defect diseases, and provides important clues and technical support for further research of action mechanisms of the eye cleaning and nursing lotion.
12. The eye cleaning and nursing lotion provided by the invention adopts a novel gas-liquid mixing device, and the gas-liquid mixing purity is high.
Compared with the prior art, the invention has the following advantages:
1. the concentration of the trioxane in the eye cleaning and nursing lotion provided by the invention is safe and does not cause damage to eyes.
2. The eye cleaning and nursing lotion provided by the invention has the two-in-one effects of oxygen supply and sterilization, and once the eye cleaning and nursing lotion is put into the market or clinically, the eye cleaning and nursing lotion pattern using the traditional normal saline as the raw material is broken.
3. Compared with the price of eye washing liquid and nursing liquid for high-end eye products such as mydriasis in the market, the eye washing and nursing lotion provided by the invention is popular with people, is beneficial to large-area popularization and sale, does not contain antibiotics, has natural sterilization and disinfection effects, is natural and drug-resistant, and is more environment-friendly and safer for use groups.
4. The subsequent related derivative products of the eye cleaning and nursing lotion provided by the invention have high feasibility in continuous development, and can be used for subsequently developing sterilization and disinfection cleaning solutions in the fields of surgical incision irrigation, wound disinfection, skin disinfection and the like by adjusting the concentration and the use environment of the trioxane eye cleaning and nursing lotion.
Drawings
FIG. 1 is a schematic view of the process of the present invention
FIG. 2 is a dynamic change in MDA content in corneal tissue
FIG. 3 is a graph showing the dynamic changes in SOD activity in corneal tissue
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
10mL of triple distilled water is taken as a basic solution, which contains 9.1mg of menthol and 0.2mL of glycerol, the pH value is 7.2-7.4, and the osmotic pressure is 240-290 mOsm/L.
The preparation method comprises the following steps: dissolving 0.2mL of glycerol and 9.1mg of menthol in the triple distilled water solution, uniformly mixing, supplementing the triple distilled water solution to 10mL, and fully mixing by adopting a high-efficiency gas-water turbine mixer. Adding 50.4ml of trioxane, fully mixing by a novel gas-liquid mixing device, adjusting the pH value to 7.2-7.4 and the osmotic pressure to 240-290mOsm/L, and filtering and sterilizing by a 0.2 mu m membrane to obtain the trioxane nursing eye drop.
Example 2
10mL of triple distilled water is taken as a basic solution, which contains 9.5mg of menthol and 0.18mL of glycerol, the pH value is 7.2-7.4, and the osmotic pressure is 240-290 mOsm/L.
The preparation method comprises the following steps: dissolving 0.18mL of glycerol and 9.5mg of menthol in the triple distilled water solution, uniformly mixing, supplementing the triple distilled water solution to 10mL, and fully mixing by adopting a high-efficiency gas-water turbine mixer. Adding 51ml of trioxane, fully mixing by a novel gas-liquid mixing device, adjusting the pH value to 7.2-7.4 and the osmotic pressure to 240-290mOsm/L, and filtering and sterilizing by a 0.2 mu m membrane to obtain the trioxane nursing eye drops.
Example 3
10mL of triple distilled water is taken as a basic solution, which contains 8.9mg of menthol and 0.15mL of glycerol, the pH value is 7.2-7.4, and the osmotic pressure is 240-290 mOsm/L.
The preparation method comprises the following steps: dissolving 0.15mL of glycerol and 8.9mg of menthol in the triple distilled water solution, uniformly mixing, supplementing the triple distilled water solution to 10mL, and fully mixing by adopting a high-efficiency gas-water turbine mixer. Adding 50ml of trioxane, fully mixing by a novel gas-liquid mixing device, adjusting the pH value to 7.2-7.4 and the osmotic pressure to 240-280 mOsm/L, and filtering and sterilizing by a 0.2 mu m membrane to obtain the trioxane nursing eye drop.
Example 4
10mL of triple distilled water is taken as a basic solution, which contains 9mg of menthol and 0.2mL of glycerol, the pH value is 7.2-7.4, and the osmotic pressure is 240-290 mOsm/L.
The preparation method comprises the following steps: dissolving 0.2mL of glycerol and 9mg of menthol in the triple distilled water solution, uniformly mixing, supplementing the triple distilled water solution to 10mL, and fully mixing by adopting a high-efficiency gas-water turbine mixer. Adding 50.4ml of trioxane, fully mixing by a novel gas-liquid mixing device, adjusting the pH value to 7.2-7.4 and the osmotic pressure to 240-290mOsm/L, and filtering and sterilizing by a 0.2 mu m membrane to obtain the trioxane nursing eye drop.
Example 5: the present invention is not described in detail, but is known to those skilled in the art. Finally, the above embodiments are only for illustrating the technical solutions of the present invention and not for limiting, although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions may be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all of them should be covered in the claims of the present invention.
Claims (10)
1. The three-oxygen eye cleaning and nursing lotion is composed of the following components:
(A) the concentration of the trioxane eye cleaning and nursing lotion is 2ug/ml to 10 ug/ml.
(B menthol 1 ug/ml-20 ug/ml.
(C) Glycerin is 3ug/ml to 30 ug/ml.
(D) The balance of three distilled water.
2. The trioxane eye cleaning and nursing lotion according to claim 1, wherein the solution is mixed by a novel gas-liquid mixing device.
3. The trioxyhcartridge eye cleaning and care lotion of claim 1, wherein the trioxyhcartridge eye cleaning and care lotion is ready to use, ready to be pre-made and packaged.
4. The trioxane eye cleaning and nursing lotion according to claim 1, wherein the application method of the trioxane eye cleaning and nursing lotion comprises directly dripping on the eyeball surface, dripping on the eyelid and dripping in the conjunctival sac.
5. The trioxyhydrous eye cleaning and care lotion according to claim 1, wherein the pH of the trioxyhydrous eye cleaning and care lotion is adjusted to 6.0-8.0.
6. The trioxyhydrous eye cleaning and care lotion according to claim 1, wherein the osmotic pressure of the trioxyhydrous eye cleaning and care lotion is 240-290 mOsm/L.
7. The trioxonic eye cleaning and care lotion according to claim 1, wherein the trioxonic eye cleaning and care lotion is characterized by being a mixture of a water-soluble organic solvent and a water-soluble organic solvent. Filtering and sterilizing by a 0.2 mu m membrane.
8. The eye cleaning and nursing lotion containing trioxid as claimed in claim 1, wherein a certain amount of menthol is added into the eye cleaning and nursing lotion containing trioxid, so that the skin penetration of the medicine can be significantly improved, and the effect is significant.
9. The trioxyhydrous eye cleaning and care lotion according to claim 1, wherein a certain amount of glycerin is added to the trioxyhydrous eye cleaning and care lotion, so that the comfort of eyes can be obviously improved, and the trioxyhydrous eye cleaning and care lotion has a moisturizing effect.
10. The trioxyhydrous eye cleaning and nursing lotion according to claim 1, wherein the trioxyhydrous eye cleaning and nursing lotion is free from hormone components, can be used for a long time, and greatly reduces complications and sequelae during the application of the lotion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910930747.XA CN112535690A (en) | 2019-09-20 | 2019-09-20 | Oxygen supply and sterilization integrated ozone eye cleaning and nursing lotion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910930747.XA CN112535690A (en) | 2019-09-20 | 2019-09-20 | Oxygen supply and sterilization integrated ozone eye cleaning and nursing lotion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112535690A true CN112535690A (en) | 2021-03-23 |
Family
ID=75013176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910930747.XA Pending CN112535690A (en) | 2019-09-20 | 2019-09-20 | Oxygen supply and sterilization integrated ozone eye cleaning and nursing lotion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112535690A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113440478A (en) * | 2021-07-02 | 2021-09-28 | 高州市人民医院 | Eye care solution |
-
2019
- 2019-09-20 CN CN201910930747.XA patent/CN112535690A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 王心如, 中国协和医科大学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113440478A (en) * | 2021-07-02 | 2021-09-28 | 高州市人民医院 | Eye care solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO338991B1 (en) | Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations | |
| CN105853260B (en) | A kind of diaper dermatitis frost and preparation method thereof | |
| CN108210689A (en) | A kind of canker sore film containing hyaluronic acid and preparation method thereof | |
| CN106110389A (en) | A kind of moist dressing of skin wound and its preparation method and application | |
| CN102066402B (en) | Peptide derivative and composition for promoting tear secretion comprising the same | |
| CN114376964B (en) | Puerarin nanoparticle film-forming hydrogel preparation and preparation method thereof | |
| CN107519236A (en) | A kind of topical agent for treating onychomycosis | |
| CN105012235B (en) | A kind of ophthalmically acceptable antimycotic nano micellar solution containing terbinafine HCl | |
| CN109833431A (en) | A kind of bacteriostatic gel and preparation method thereof | |
| CN112535690A (en) | Oxygen supply and sterilization integrated ozone eye cleaning and nursing lotion | |
| CN102100665B (en) | Eye drops containing vitamin E derivatives and preparation method thereof | |
| KR102249700B1 (en) | Comsmetic composition comprising mint vinegar | |
| JP2000191542A (en) | Preventive/therapeutic agent for osteoporosis | |
| CN112546083A (en) | Compound preparation containing sodium aescinate for relieving swelling and pain and preparation method thereof | |
| EP2692332B1 (en) | Composition for the treatment of callus, corns and psoriasis | |
| EP3498337A1 (en) | Composition for the relief, improvement, prevention and/or treatment of dry eye syndrome | |
| CN108542883A (en) | A kind of spray that eye is applied outside | |
| CN108815175A (en) | A kind of spray that eye is applied outside | |
| CN108653304A (en) | A kind of pterostilbene nano-micelle external-use gel and preparation method thereof | |
| CN101057823B (en) | Composite biological preparation with antisenility and beautifying function | |
| CN105982882B (en) | A kind of externally applied drug and preparation process of optical active starting materials composition prescription therapeutic hemorrhoid | |
| CN108653318A (en) | Application of the ozone carburetion in eye and ear disease | |
| CN113069373A (en) | Dry eye cream, preparation method and application | |
| CN113925998A (en) | Hypochlorous acid dressing for promoting wound healing | |
| CN1330371C (en) | Recombinant human epidermal growth factor compound biological agent and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210323 |